CERO THERAPEUTICS HOLDINGS, INC.
CERO THERAPEUTICS HOLDINGS, INC. (CERO) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 26 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jan 7, 2026 involved a transaction of 1,162,099 shares valued at $0.
CERO Insider Activity Summary
Who Is Buying CERO Stock?
No significant insider buying has been recorded for CERO in the recent period.
Who Is Selling CERO Stock?
No significant insider selling has been recorded for CERO in the recent period.
Is CERO THERAPEUTICS HOLDINGS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CERO is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
CERO Frequently Asked Questions
Understanding CERO Insider Activity
Insider trading at CERO THERAPEUTICS HOLDINGS, INC. (CERO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading CERO stock, having executed 26 transactions in the past 90 days. The most active insider is Andrew Albert Kucharchuk (Chief Financial Officer), who has made 1 transactions totaling $0.
Related Tools
Track CERO THERAPEUTICS HOLDINGS, INC. Insider Activity
Get notified when executives and directors at CERO file new Form 4 transactions